Red blood cell survival in long-term dialysis patients
Researchers are also evaluating retatrutide for type 2 diabetes (TRIUMPH-2), cardiovascular outcomes (TRIUMPH-3), and other conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD)
MedPAC recommended that if ASP data is used, it should be from a longer timeframe, such as 4 calendar quarters, to avoid manipulation
Metformin treatment throughout pregnancy in women with PCOS does not cause significant adverse effects such as fetal growth retardation or intrauterine death ( 3.3.2 Effect of metformin on offspring malformations in patients with polycystic ovary syndrome The period of early pregnancy is critical for organogenesis and the potential teratogenic effects of drugs
the impact on perioperative aspiration and regurgitation risk remains unclear
Mega Doctor News Medical News Today The Food and Drug Administration (FDA) has approved Eli Lillys once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems
